Samsara BioCapital GP, LLC - Nov 14, 2023 Form 4 Insider Report for CARGO Therapeutics, Inc. (CRGX)

Role
10%+ Owner
Signature
Samsara BioCapital GP, LLC, By /s/ Srinivas Akkaraju, Managing Member
Stock symbol
CRGX
Transactions as of
Nov 14, 2023
Transactions value $
$9,999,990
Form type
4
Date filed
11/16/2023, 07:39 PM
Previous filing
Nov 9, 2023
Next filing
Feb 14, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CRGX Common Stock Conversion of derivative security +3.38M +4587.96% 3.46M Nov 14, 2023 By Samsara BioCapital, L.P. F1, F2
transaction CRGX Common Stock Purchase $10M +667K +19.3% $15.00 4.12M Nov 14, 2023 By Samsara BioCapital, L.P. F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CRGX Series Seed convertible preferred stock Conversion of derivative security $0 -663K -100% $0.00* 0 Nov 14, 2023 Common Stock 663K By Samsara BioCapital, L.P. F1, F2
transaction CRGX Series A-1 convertible preferred stock Conversion of derivative security $0 -884K -100% $0.00* 0 Nov 14, 2023 Common Stock 884K By Samsara BioCapital, L.P. F1, F2
transaction CRGX Series A-2 convertible preferred stock Conversion of derivative security $0 -1.83M -100% $0.00* 0 Nov 14, 2023 Common Stock 1.83M By Samsara BioCapital, L.P. F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each share of Series Seed convertible preferred stock, Series A-1 convertible preferred stock and Series A-2 convertible preferred stock automatically converted into shares of Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date.
F2 Shares are held by Samsara BioCapital L.P. ("Samsara LP"). Samsara BioCapital GP, LLC ("Samsara LLC") is the general partner of Samsara LP and may be deemed to beneficially own the shares held by Samsara LP. Dr. Srinivas Akkaraju, MD, Ph.D. has voting and investment power over the shares held by Samsara LP and, accordingly, may be deemed to beneficially own the shares held by Samsara LP. Each of the Reporting Persons disclaims beneficial ownership in these shares except to the extent of its or his respective pecuniary interest therein.